PrEP Campaign Aims To Grow Awareness Of HIV Prevention Treatment Among Doctors, At-Risk Californians
Marketed as Truvada, the daily pill regimen helps protect people against the spread of HIV but many doctors still have little info about it. In other public health news, women are reminded to discuss cervical cancer risks with their physician.
The Sacramento Bee:
Doctors, Activists Push For New PrEP Treatment To Prevent HIV Spread
Research by the federal Centers for Disease Control and Prevention has shown that taking Truvada once a day can lower the chances of getting HIV by more than 90 percent for people having sex and more than 70 percent for injection drug users. That’s good news for people who have sex with multiple partners, those in a relationship with someone who’s HIV-positive, sex workers or anyone else at risk, said Janet Parker, director of strategy and market development at Cares Community Health, Sacramento’s nonprofit hub for HIV and AIDS treatment. (Caiola, 2/2)
The Bakersfield Californian:
The Power To Prevent Cervical Cancer
A new year serves as a reminder for women to talk with their physicians about the risks of developing cervical cancer, what causes it and what you can do to prevent it. Through the Community Health Advocates implementing Nationwide Grants for Empowerment and Equity (CHANGE) program, the Anthem Blue Cross Foundation has awarded funding to the American Cancer Society to help Omni Family Health (National Health Services, Inc.) of Bakersfield provide cervical cancer education and screening to underserved women. (Saslow and Asher, 2/2)